Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice. Vercauteren, K, Brown, R J, Mesalam, A A, Doerrbecker, J, Bhuju, S, Geffers, R, Van Den Eede, N, McClure, C P, Troise, F, Verhoye, L, Baumert, T, Farhoudi, A, Cortese, R, Ball, J K, Leroux-Roels, G, Pietschmann, T, Nicosia, A, & Meuleman, P Gut, in press.
bibtex   
@article{vercautereninpresstargeting,
  author = {Vercauteren, K and Brown, R J and Mesalam, A A and Doerrbecker, J and Bhuju, S and Geffers, R and Van Den Eede, N and McClure, C P and Troise, F and Verhoye, L and Baumert, T and Farhoudi, A and Cortese, R and Ball, J K and Leroux-Roels, G and Pietschmann, T and Nicosia, A and Meuleman, P},
  editor = {Gut},
  interhash = {f8ae43c860c31c97b37a2fb4f88deb8a},
  intrahash = {3e7e8bc211862d4d458f320437f28243},
  journal = {Gut},
  pubmedurl = {10.1136/gutjnl-2014-309045},
  title = {Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice},
  volume = {doi: 10.1136/gutjnl-2014-309045},
  year = {in press}
}

Downloads: 0